115 related articles for article (PubMed ID: 18383827)
1. Volume-sensitive Cl(-) channel as a regulator of acquired cisplatin resistance.
Shimizu T; Lee EL; Ise T; Okada Y
Anticancer Res; 2008; 28(1A):75-83. PubMed ID: 18383827
[TBL] [Abstract][Full Text] [Related]
2. Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells.
Lee EL; Shimizu T; Ise T; Numata T; Kohno K; Okada Y
J Cell Physiol; 2007 May; 211(2):513-21. PubMed ID: 17186499
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells.
Min XJ; Li H; Hou SC; He W; Liu J; Hu B; Wang J
Exp Biol Med (Maywood); 2011 Apr; 236(4):483-91. PubMed ID: 21454376
[TBL] [Abstract][Full Text] [Related]
4. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
[TBL] [Abstract][Full Text] [Related]
5. Codominance of cisplatin resistance in somatic cell hybrids.
Ying YL; Shen DW; Liang XJ; Gottesman MM
J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
[TBL] [Abstract][Full Text] [Related]
6. Roles of volume-sensitive Cl- channel in cisplatin-induced apoptosis in human epidermoid cancer cells.
Ise T; Shimizu T; Lee EL; Inoue H; Kohno K; Okada Y
J Membr Biol; 2005 Jun; 205(3):139-45. PubMed ID: 16362502
[TBL] [Abstract][Full Text] [Related]
7. Impaired actin filaments decrease cisplatin sensitivity via dysfunction of volume-sensitive Cl
Shimizu T; Fujii T; Ohtake H; Tomii T; Takahashi R; Kawashima K; Sakai H
J Cell Physiol; 2020 Dec; 235(12):9589-9600. PubMed ID: 32372464
[TBL] [Abstract][Full Text] [Related]
8. Volume-sensitive outwardly rectifying chloride channels are involved in oxidative stress-induced apoptosis of mesangial cells.
Jiao JD; Xu CQ; Yue P; Dong DL; Li Z; Du ZM; Yang BF
Biochem Biophys Res Commun; 2006 Feb; 340(1):277-85. PubMed ID: 16364252
[TBL] [Abstract][Full Text] [Related]
9. IK1 channel activity contributes to cisplatin sensitivity of human epidermoid cancer cells.
Lee EL; Hasegawa Y; Shimizu T; Okada Y
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1398-406. PubMed ID: 18367588
[TBL] [Abstract][Full Text] [Related]
10. Regulation of volume-sensitive Cl- channels in multi-drug resistant MCF7 cells.
Marin M; Poret A; Maillet G; Leboulenger F; Le Foll F
Biochem Biophys Res Commun; 2005 Sep; 334(4):1266-78. PubMed ID: 16039989
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation and altered localization of gamma-catenin in cisplatin-resistant adenocarcinoma cells.
Liang XJ; Shen DW; Gottesman MM
Mol Pharmacol; 2004 May; 65(5):1217-24. PubMed ID: 15102950
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells.
Yoon SJ; Park I; Kwak C; Lee E
Oncol Rep; 2003; 10(5):1363-7. PubMed ID: 12883708
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system.
Nakagawa H; Ohira M; Hayashi S; Abe S; Saito S; Nagahori N; Monde K; Shinohara Y; Fujitani N; Kondo H; Akiyama S; Nakagawara A; Nishimura S
Cancer Lett; 2008 Nov; 270(2):295-301. PubMed ID: 18573595
[TBL] [Abstract][Full Text] [Related]
14. Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells.
Mukai M; Kanzaki A; Chen ZS; Miyashita H; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Takamatsu H; Akiyama S
Oncol Rep; 2002; 9(4):839-44. PubMed ID: 12066219
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
16. Understanding cisplatin resistance using cellular models.
Stordal B; Davey M
IUBMB Life; 2007 Nov; 59(11):696-9. PubMed ID: 17885832
[TBL] [Abstract][Full Text] [Related]
17. Increased glutathione level is not involved in enhanced bleomycin sensitivity in cisplatin-resistant 2780CP cells.
Tanaka T; Kurokawa H; Matsuno K; Matsumoto S; Hayashida Y
Anticancer Res; 2008; 28(5A):2663-8. PubMed ID: 19035292
[TBL] [Abstract][Full Text] [Related]
18. Volume-sensitive chloride channels are involved in cisplatin treatment of osteosarcoma.
Cai S; Zhang T; Zhang D; Qiu G; Liu Y
Mol Med Rep; 2015 Apr; 11(4):2465-70. PubMed ID: 25503821
[TBL] [Abstract][Full Text] [Related]
19. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
Hrstka R; Powell DJ; Kvardova V; Roubalova E; Bourougaa K; Candeias MM; Sova P; Zak F; Fåhraeus R; Vojtĕsek B
Anticancer Drugs; 2008 Apr; 19(4):369-79. PubMed ID: 18454047
[TBL] [Abstract][Full Text] [Related]
20. Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance.
Liang XJ; Taylor B; Cardarelli C; Yin JJ; Annereau JP; Garfield S; Wincovitch S; Szakács G; Gottesman MM; Aszalos A
Anticancer Res; 2005; 25(6B):4113-22. PubMed ID: 16309205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
